Research Use Only - Important Disclaimer
All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.
Adipotide
Peptide for Research
Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide designed to induce targeted apoptosis of fat cells, potentially resulting in rapid reduction of body fat in animal studies.
Usage:
Primarily used in research settings to investigate its effects on body weight reduction, fat loss, and metabolic health. Not approved for human use.
Mechanism of Action:
Adipotide targets specific proteins on the surface of fat cell blood vessels (Prohibitin and ANXA2), causing apoptosis (cell death) in the blood vessels supplying white adipose tissue. This leads to fat cell death and subsequent reduction of fat mass.
Benefits:
- Rapid fat loss observed in animal studies
- Reduces white adipose tissue
- Potential metabolic improvements (e.g., insulin sensitivity)
- Non-stimulant fat loss mechanism
Side Effects:
- Dehydration
- Mild to moderate kidney stress (noted in primate studies)
- Electrolyte imbalance
- Potential for nausea, lethargy, and other systemic effects
Suggested Dosage:
Not specified
Half-life: 2–4 hours (in animal studies; human data not established)
Delivery: Subcutaneous injection (for research use only)